CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
The acquisition complements Gilead’s existing oncology expertise and development infrastructure
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The acquisition brings two commercialized, differentiated medicines—EMPAVELI and SYFOVRE —to Biogen’s growth portfolio
The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases
Lonza will take on technology transfer, process optimization, and cGMP manufacturing, leveraging its global network and expertise in highly potent compounds
The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners
The approval covers pediatric patients without a matched sibling donor for stem cell transplant
Subscribe To Our Newsletter & Stay Updated
